Metrics as of 10/16/2026, 08:31 AM (Berlin time), refresh in progress.
Hyperfine Stock
Hyperfine, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Maria Degois Sainz
- Employees
- 102
- Market cap
- $69 M
- IPO
- 28/01/2021
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and…
Hyperfine stock: price history
1D
-3.2%
1W
-18.9%
1M
-2.5%
6M
-42.4%
YTD
-22.9%
1Y
-46.8%
2Y
-24.5%
5Y
-92.4%
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~31% stronger price swings than usual
Ask the agents about Hyperfine
Analyst assessment of Hyperfine
PRICE TARGET LOW
US$2.00
CONSENSUS
US$2.00
MEDIAN
US$2.00
PRICE TARGET HIGH
US$2.00
0
STRONG BUY
4
BUY
1
HOLD
0
SELL
0
STRONG SELL
5
TOTAL · Buy
As of: 22/09/2026
Hyperfine stock metrics
P/E
-1.97
P/B
2.05
EV/EBITDA
-1.17
RETURN ON EQUITY
-25.3%
NET MARGIN
-238.2%
DEBT/EQUITY
0.36
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
79.0%
FLOAT SHARES
71,911,734
AVG. DAILY VOLUME (30D)
970,606
Insider transactions (SEC)
HALE BRETT
TEISSEYRE THOMAS
TEISSEYRE THOMAS
HALE BRETT
Institutional holders
Comparable stocks
Frequently asked questions about Hyperfine stock
What does Hyperfine do?
Hyperfine, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Maria Degois Sainz, the company employs around 102 people.
The IPO was on 28/01/2021; the stock trades on NASDAQ under the ticker HYPR.
What do analysts say about Hyperfine stock?
5 analysts rate the stock, the consensus is Buy (as of 22/09/2026).
The average price target is US$2.00, ranging from US$2.00 to US$2.00, with a median of US$2.00.
This is an external assessment, not a statement by Market Jury.
When does Hyperfine report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 31% stronger than usual.
Does Hyperfine pay a dividend?
No, Hyperfine currently does not pay a dividend.
Which stocks are comparable to Hyperfine?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Hyperfine stock analyzed?
Clicking "Analyze stock" lets five strategies assess Hyperfine against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.